RhumbLine Advisers
MRM

RhumbLine Advisers’s MEDIROM Healthcare Technologies MRM Stock Holding History

RhumbLine Advisers’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2K Buy
3,104
+1,120
+56% +$1.26K ﹤0.01% 3987
2026
Q1 		$2.22K Sell
1,984
-2,269
-53% -$3.29K ﹤0.01% 3930
2025
Q4 		$8.25K Buy
4,253
+2,946
+225% +$6.32K ﹤0.01% 3875
2025
Q3 		$2.77K Buy
1,307
+207
+19% +$347 ﹤0.01% 3961
2025
Q2 		$1.54K Buy
+1,100
New +$1.22K ﹤0.01% 4011

Other funds holding MRM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

RhumbLine Advisers's MRM Position: Q2 2026 in Review

RhumbLine Advisers increased its MEDIROM Healthcare Technologies (MRM) stake by 56% in Q2 2026, buying an estimated $1.26K and bringing the position to 3,104 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3987.

RhumbLine Advisers first reported a position in MRM in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.25K in Q4 2025. 8 funds tracked by Wall St. Rank hold MRM as of Q2 2026.

  • RhumbLine Advisers held 3,104 shares of MEDIROM Healthcare Technologies worth $3.2K as of Q2 2026.
  • RhumbLine Advisers bought 1,120 MEDIROM Healthcare Technologies shares in Q2 2026, an estimated $1.26K.
  • MEDIROM Healthcare Technologies made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3987 holding.
  • RhumbLine Advisers first reported a position in MEDIROM Healthcare Technologies in Q2 2025 and has held it in 5 quarters since.
  • RhumbLine Advisers's MEDIROM Healthcare Technologies position peaked at $8.25K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.